Skip to main content

HTG Molecular Diagnostics, Inc

HTGMDelisted Jul 10, 2023
Industry
Laboratory Analytical Instruments
SEC CIK
0001169987

HTG Molecular Diagnostics, Inc was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jun 9, 2023; 12 institutions reported holding it in 13F filings for Q1 2023, worth $67.3K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
12
Q1 2023, +2 vs. previous quarter
13F value
$67.3K
Reported value at the end of Q1 2023
Superinvestors holding
0
At the end of Q1 2023

Superinvestors holding HTGM, Q1 2023

Go to the superinvestors tab

No superinvestor reported holding HTGM at the end of Q1 2023.

Latest insider trades

Open-market purchases and sales by HTG Molecular Diagnostics, Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 9, 2023 (view filing)Jun 81 dayBarat StephenSenior VP of TherapeuticsSSale−888$0.80−$710.4−67.8%421 after

Top 10 13F holders, Q1 2023

The largest institutional positions in HTG Molecular Diagnostics, Inc at the end of Q1 2023; share changes are against Q4 2022.

See all 12 holders
Institutions holding HTGM in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc14,692$39.7K0.00%+14,692New
UBS Group AG5,198$14.0K0.00%+3,223+163.2%Added
Tower Research Capital LLC (TRC)1,481$4.00K0.00%−5,208−77.9%Reduced
BlackRock Inc.1,289$3.48K0.00%−4,815−78.9%Reduced
Morgan Stanley884$2.39K0.00%00.0%Unchanged
HighMark Wealth Management LLC580$1.57K0.00%00.0%Unchanged
Nordwand Advisors, LLC500$1.35K0.00%+500New
Allworth Financial LP279$7540.00%+2+0.7%Added
Wells Fargo & Company13$350.00%+9+225.0%Added
TCI Wealth Advisors, Inc.2$60.00%00.0%Unchanged